Cost–effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC)
Sang Gyu Lee, Young Geon Jee, Hyun Chul Chung, Sung-Bae Kim, Jungsil Ro, Young-Hyuck Im, Seock-Ah Im, Jae Hong SeoVolume:
114
Language:
english
Pages:
7
DOI:
10.1007/s10549-008-0035-0
Date:
April, 2009
File:
PDF, 231 KB
english, 2009